Twin Peaks Wealth Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$75	Buy	+18	New	+$87	﹤0.01%	2269

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $221M AUM

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Twin Peaks Wealth Advisors's SRTA Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in Strata Critical Medical Inc (SRTA) in Q1 2026: 18 shares worth $75. The stake represents ﹤0.01% of the portfolio and ranks #2269 among its holdings.

125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

Twin Peaks Wealth Advisors held 18 shares of Strata Critical Medical Inc worth $75 as of Q1 2026.
Strata Critical Medical Inc was a new Twin Peaks Wealth Advisors position in Q1 2026.
Strata Critical Medical Inc made up ﹤0.01% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #2269 holding.
125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.